The Changing World of European Health Lobbies

Health seems like an unlikely candidate for Europeanization. It is at the core of the welfare state, vitally important to member states and their politicians, and consequently long protected from European Union (EU) policy. EU treaties have only weak and tightly delimited health policy competencies, reflecting member states’ unwillingness to countenance EU (or any outside) intervention in health. The interest group ecology is also tightly bound to states, no matter how international the conference circuit. Even in countries with little or no corporatism, such as the United Kingdom, there is a great deal of ‘private interest government’ in health (Streeck and Schmitter 1985; Salter 2004). In such tightly drawn policy sectors, Europeanization of interests and policymaking might be a dramatic shock for policy-makers, and a dramatic case study of theories of European politics and integration for the scholars. The development of EU health policy is giving scholars just that case study. A fledgling European health policy arena is developing as a result of exogenous shocks to existing systems administered by the Court and Commission. I argue that investment by interest groups and policy advocates in EU health lobbying is in response to either the explicit efforts of the Commission to win allies for new policy ventures (so far mostly in public health) or a defensive reaction to the increasingly complex and important EU judicial and legislative agenda in health services, consistent with the findings of Wessels that groups become engaged when they realize the EU is potentially engaged with their issue (Wessels 2004). Groups that would be interested in liberalization ‐ seemingly just what the EU health services agenda provides ‐ are focusing not on helping the liberalizers at the EU level but on developing connections in member states. The result is NGO and professional dominance that stands in contrast to the usual EU pattern in which business dominates lobbying. It also poses the

[1]  M. Mckee,et al.  Patient mobility in the European Union : learning from experience , 2006 .

[2]  M. Mckee,et al.  The role and function of hospitals , 2002 .

[3]  D. Josselin Domestic policy networks and European negotiations: Evidence from British and French financial services , 1996 .

[4]  Lisa Conant,et al.  Justice Contained: Law and Politics in the European Union , 2002 .

[5]  M. Lodge Varieties of Europeanisation and the National Regulatory State , 2002 .

[6]  Paul A. Sabatier,et al.  The advocacy coalition framework: revisions and relevance for Europe , 1998 .

[7]  D. Coen,et al.  Insider and Outsider Lobbying of the European Commission , 2003 .

[8]  Susan K. Sell,et al.  Using Ideas Strategically: The Contest Between Business and NGO Networks in Intellectual Property Rights , 2004 .

[9]  Wolfgang Streeck,et al.  Private interest government : beyond market and state , 1988, American Political Science Review.

[10]  S. Giubboni Social Rights and Market Freedom in the European Constitution: A Labour Law Perspective , 2006 .

[11]  R. Busse,et al.  The European union and health services : the impact of the single European market on member states , 2002 .

[12]  Mitchell P. Smith States of Liberalization: Redefining the Public Sector in Integrated Europe , 2005 .

[13]  Hank C. Jenkins-Smith,et al.  Evaluating the Advocacy Coalition Framework , 1994, Journal of Public Policy.

[14]  R. Baggott Public Health : Policy and Politics , 2000 .

[15]  Robert R. Alford Health Care Politics: Ideological and Interest Group Barriers to Reform , 1975 .

[16]  G. Permanand EU pharmaceutical regulation: The politics of policy-making , 2006 .

[17]  L. Ackers,et al.  Senior citizenship?: Retirement, migration and welfare in the European Union , 2002 .

[18]  Jeremy Richardson,et al.  Government, Interest Groups and Policy Change , 2000 .

[19]  W. Streeck,et al.  Governing Interests: Business Associations Facing Internationalization , 2006 .

[20]  David J. Hunter,et al.  Public health policy , 2013 .

[21]  Elias Mossialos,et al.  Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality , 2004 .

[22]  R. V. Schendelen,et al.  Machiavelli in Brussels: The Art of Lobbying the EU , 2002 .

[23]  J. Oliver Fat Politics: The Real Story Behind America's Obesity Epidemic , 2005 .

[24]  T. Hervey,et al.  Health Law and the European Union , 2004 .

[25]  The Europeanization of Business Interest Representation: UK and French Firms Compared , 2003 .

[26]  A. Farrell The emergence of EU governance in public health: The case of EU blood policy and regulation , 2005 .

[27]  B. Wessels European Integration and Political Conflict: Contestation potential of interest groups in the EU: emergence, structure, and political alliances , 2004 .

[28]  J. Beyers Gaining and seeking access: The European adaptation of domestic interest associations , 2002 .